| scholarly article | Q13442814 |
| P2093 | author name string | Marko Hočevar | |
| Janez Zgajnar | |||
| Petra Cerkovnik | |||
| Vida Stegel | |||
| Srdjan Novaković | |||
| Mateja Krajc | |||
| Aleš Vakselj | |||
| Maša Milatović | |||
| P2860 | cites work | Purified human BRCA2 stimulates RAD51-mediated recombination | Q24297031 |
| Maspin is a tumour suppressor that inhibits breast cancer tumour metastasis in vivo | Q24802539 | ||
| BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure | Q27639649 | ||
| Maspin sensitizes breast carcinoma cells to induced apoptosis | Q28201692 | ||
| Unraveling the mechanism of BRCA2 in homologous recombination | Q28242443 | ||
| Biallelic inactivation of BRCA2 in Fanconi anemia | Q29616130 | ||
| Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study | Q30433040 | ||
| A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer | Q33269617 | ||
| Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis | Q33289120 | ||
| The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population | Q33792732 | ||
| Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection | Q33853726 | ||
| Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features | Q33892942 | ||
| Variation in cancer risks, by mutation position, in BRCA2 mutation carriers | Q34044197 | ||
| Estimates of cancer incidence and mortality in Europe in 2008. | Q34095813 | ||
| Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains. | Q34109816 | ||
| Understanding missense mutations in the BRCA1 gene: an evolutionary approach | Q34329529 | ||
| Cancer Incidence in BRCA1 mutation carriers | Q34527264 | ||
| A high proportion of founder BRCA1 mutations in Polish breast cancer families | Q34548008 | ||
| A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer. | Q35000825 | ||
| BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients | Q35527158 | ||
| Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece | Q35619211 | ||
| Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases | Q35630889 | ||
| Time to reconsider subcutaneous mastectomy for breast-cancer prevention? | Q36145219 | ||
| BRCA1, a potential predictive biomarker in the treatment of breast cancer | Q36734477 | ||
| Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. | Q37004481 | ||
| Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes | Q37034495 | ||
| BRCA1 and BRCA2: different roles in a common pathway of genome protection | Q37149848 | ||
| The BRC repeats of human BRCA2 differentially regulate RAD51 binding on single- versus double-stranded DNA to stimulate strand exchange | Q37272458 | ||
| American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility | Q37672016 | ||
| Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval | Q39712677 | ||
| Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase. | Q39781851 | ||
| Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. | Q40717542 | ||
| Genetic susceptibility to breast cancer | Q41130542 | ||
| Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany | Q43074872 | ||
| Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada | Q44116893 | ||
| Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer | Q46855999 | ||
| Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study. | Q46926668 | ||
| Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia | Q50060965 | ||
| Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2. | Q54441588 | ||
| [Analysis of BRCA2 gene mutations among familial and/or early-onset breast cancer patients in eastern Shandong of China]. | Q54538510 | ||
| Clinical implications for BRCA gene mutation in breast cancer. | Q54580068 | ||
| A DGGE system for comprehensive mutation screening ofBRCA1andBRCA2: application in a Dutch cancer clinic setting | Q57200495 | ||
| Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations | Q57266547 | ||
| Clinical Classification ofBRCA1andBRCA2DNA Sequence Variants: The Value of Cytokeratin Profiles and Evolutionary Analysis—A Report From the kConFab Investigators | Q57306048 | ||
| Unclassified variants in BRCA genes: guidelines for interpretation | Q60170551 | ||
| Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene | Q71955901 | ||
| Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations | Q73376457 | ||
| TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors | Q74409735 | ||
| Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk | Q74784103 | ||
| Germline BRCA1 alterations in a population-based series of ovarian cancer cases | Q77298998 | ||
| Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers | Q78688118 | ||
| EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients | Q82682188 | ||
| Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer | Q83155542 | ||
| BRCA1 and BRCA2 mutations in a South American population | Q83157294 | ||
| Fanconi anemia gene mutations are not involved in sporadic Wilms tumor | Q84505265 | ||
| BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells | Q84886081 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 1619-1627 | |
| P577 | publication date | 2012-08-21 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families | |
| P478 | volume | 41 |
| Q42181679 | A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer |
| Q39199102 | Aggregate penetrance of genomic variants for actionable disorders in European and African Americans |
| Q36286597 | BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer |
| Q35710253 | Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup |
| Q38836844 | Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks |
| Q38663391 | Genetic Counselling, BRCA1/2 Status and Clinico-pathologic Characteristics of Patients with Ovarian Cancer before 50 Years of Age. |
| Q91081319 | Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia |
| Q48163026 | Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin. |
| Q94585170 | The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer |
| Q47196697 | The first case report of a large deletion of the BRCA1 gene in Croatia: A case report |
Search more.